Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Artichoke leaf extract, as AKR1B1 inhibitor, decreases sorbitol level in the rat eye lenses under high glucose conditions ex vivo

I. Šušaníková, J. Balleková, M. Štefek, J. Hošek, P. Mučaji,

. 2018 ; 32 (12) : 2389-2395. [pub] 20180815

Language English Country England, Great Britain

Document type Journal Article

Grant support
APVV-15-0308 Agentúra Ministerstva školstva, vedy, výskumu a športu SR
APVV-16-0207 Agentúra Ministerstva školstva, vedy, výskumu a športu SR
FaF UK/6/2016 Faculty of Pharmacy, Comenius University in Bratislava
VEGA 1/0290/16 Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
VEGA 1/0359/18 Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
VEGA 1/0561/18 Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
VEGA 2/0041/15 Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
IGA VFU 313/2018/FaF Veterinární a Farmaceutická Univerzita Brno

In the previous study, the artichoke leaf extract showed effective inhibition of AKR1B1, the first enzyme of polyol pathway, which reduces high level of glucose to osmotically active sorbitol, important for development of chronic diabetic complications. In the present study, the effect of artichoke leaf extract and of several participating phenols (caffeic acid, chlorogenic acid, quinic acid, and luteolin) was tested on sorbitol level in rat lenses exposed to high glucose ex vivo, on cytotoxicity as well as on oxidative stress in C2C12 muscle cell line induced by high glucose in vitro. The concentration of sorbitol was determined by enzymatic analysis, the cytotoxicity was provided by WST-1 test and intracellular content of reactive oxygen species was determined by fluorescence of 2'-7'-dichlorofluorescein probe. The extract and the compounds tested showed significant protection against toxic effects of high concentration of glucose in both models. On balance, the artichoke leaf extract thus represents a prospective preventive agent of development of chronic diabetic complications, probably due to phenols content, concerning preclinical and clinical studies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028268
003      
CZ-PrNML
005      
20191210142352.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ptr.6174 $2 doi
035    __
$a (PubMed)30109747
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šušaníková, Ivana $7 xx0242993 $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
245    10
$a Artichoke leaf extract, as AKR1B1 inhibitor, decreases sorbitol level in the rat eye lenses under high glucose conditions ex vivo / $c I. Šušaníková, J. Balleková, M. Štefek, J. Hošek, P. Mučaji,
520    9_
$a In the previous study, the artichoke leaf extract showed effective inhibition of AKR1B1, the first enzyme of polyol pathway, which reduces high level of glucose to osmotically active sorbitol, important for development of chronic diabetic complications. In the present study, the effect of artichoke leaf extract and of several participating phenols (caffeic acid, chlorogenic acid, quinic acid, and luteolin) was tested on sorbitol level in rat lenses exposed to high glucose ex vivo, on cytotoxicity as well as on oxidative stress in C2C12 muscle cell line induced by high glucose in vitro. The concentration of sorbitol was determined by enzymatic analysis, the cytotoxicity was provided by WST-1 test and intracellular content of reactive oxygen species was determined by fluorescence of 2'-7'-dichlorofluorescein probe. The extract and the compounds tested showed significant protection against toxic effects of high concentration of glucose in both models. On balance, the artichoke leaf extract thus represents a prospective preventive agent of development of chronic diabetic complications, probably due to phenols content, concerning preclinical and clinical studies.
650    _2
$a aldehydreduktasa $x antagonisté a inhibitory $7 D000449
650    _2
$a zvířata $7 D000818
650    _2
$a kultivované buňky $7 D002478
650    _2
$a Cynara scolymus $x chemie $7 D031943
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a glukosa $x farmakologie $7 D005947
650    _2
$a oční čočka $x účinky léků $x metabolismus $7 D007908
650    _2
$a myši $7 D051379
650    _2
$a orgánové kultury - kultivační techniky $7 D009924
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a rostlinné extrakty $x farmakologie $7 D010936
650    _2
$a listy rostlin $x chemie $7 D018515
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a reaktivní formy kyslíku $x farmakologie $7 D017382
650    _2
$a sorbitol $x metabolismus $7 D013012
655    _2
$a časopisecké články $7 D016428
700    1_
$a Balleková, Jana $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Štefek, Milan $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Hošek, Jan $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Mučaji, Pavel $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
773    0_
$w MED00003832 $t Phytotherapy research : PTR $x 1099-1573 $g Roč. 32, č. 12 (2018), s. 2389-2395
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30109747 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20191210142650 $b ABA008
999    __
$a ok $b bmc $g 1433417 $s 1066728
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 32 $c 12 $d 2389-2395 $e 20180815 $i 1099-1573 $m PTR. Phytotherapy research $n Phytother Res $x MED00003832
GRA    __
$a APVV-15-0308 $p Agentúra Ministerstva školstva, vedy, výskumu a športu SR
GRA    __
$a APVV-16-0207 $p Agentúra Ministerstva školstva, vedy, výskumu a športu SR
GRA    __
$a FaF UK/6/2016 $p Faculty of Pharmacy, Comenius University in Bratislava
GRA    __
$a VEGA 1/0290/16 $p Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
GRA    __
$a VEGA 1/0359/18 $p Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
GRA    __
$a VEGA 1/0561/18 $p Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
GRA    __
$a VEGA 2/0041/15 $p Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
GRA    __
$a IGA VFU 313/2018/FaF $p Veterinární a Farmaceutická Univerzita Brno
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...